Article 117 of the new EU MDR

Although short, Article 117 has significant impact to the manufacturers of integral drug-device combination products (for example pre-filled syringes, pre-filled injector pens or novel pre-filled devices) and device manufacturers that supply their products to be sold with pharmaceutical or biopharmaceutical products (for example an empty syringe).

Do you have EU MDR questions? Network Partners can help you navigate the new regulations.

Download your Article 117 white paper today